Cargando…
Early Growth Response 4 Is Involved in Cell Proliferation of Small Cell Lung Cancer through Transcriptional Activation of Its Downstream Genes
Small cell lung cancer (SCLC) is aggressive, with rapid growth and frequent bone metastasis; however, its detailed molecular mechanism remains poorly understood. Here, we report the critical role of early growth factor 4 (EGR4), a DNA-binding, zinc-finger transcription factor, in cell proliferation...
Autores principales: | Matsuo, Taisuke, Dat, Le Tan, Komatsu, Masato, Yoshimaru, Tetsuro, Daizumoto, Kei, Sone, Saburo, Nishioka, Yasuhiko, Katagiri, Toyomasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239076/ https://www.ncbi.nlm.nih.gov/pubmed/25411851 http://dx.doi.org/10.1371/journal.pone.0113606 |
Ejemplares similares
-
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
por: Kim, Nam-Hee, et al.
Publicado: (2015) -
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
por: Yoshimaru, Tetsuro, et al.
Publicado: (2015) -
Functional genomics for breast cancer drug target discovery
por: Yoshimaru, Tetsuro, et al.
Publicado: (2021) -
The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3‐PHB2 complex formation
por: Toki, Shunichi, et al.
Publicado: (2021) -
Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2013)